Bruker Corp
NASDAQ:BRKR
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
29.35
58.15
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Bruker Corp
NASDAQ:BRKR
|
7.6B USD |
Loading...
|
|
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.3T USD |
Loading...
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
236.9B USD |
Loading...
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
165.5B USD |
Loading...
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
37.6B CHF |
Loading...
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
40.1B USD |
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
279.2B CNY |
Loading...
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
38.2B USD |
Loading...
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
46.3T KRW |
Loading...
|
|
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
28.8B USD |
Loading...
|
|
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
20.3B EUR |
Loading...
|
Market Distribution
| Min | -4 418 600% |
| 30th Percentile | -9.6% |
| Median | 3.1% |
| 70th Percentile | 11.3% |
| Max | 1 135 400% |
Other Profitability Ratios
Bruker Corp
Glance View
Bruker Corporation, a prominent entity in the analytical instrumentation sector, traces its roots back to Germany. Wholly devoted to advancing science and industry through meticulous precision, Bruker has carved out a niche in creating sophisticated analytical instruments that enable comprehensive research and diagnostics. Their portfolio spans a diverse range of technologies, including mass spectrometry, magnetic resonance imaging, X-ray analysis, and molecular spectroscopy, all meticulously designed to meet the exacting demands of their clientele. These sophisticated tools empower researchers, scientists, and industrial operators to obtain insights into the fundamental properties of materials and substances, thereby driving forward discoveries in medicine, chemistry, and material science. Bruker's financial health rests on a business model grounded in both innovation and strategic expansion. They generate revenue through the sale of their high-precision instruments as well as a steadily growing service segment that ensures their equipment remains at the cutting edge of functionality and reliability. Additionally, the company pursues collaborative ventures with academic institutions and industrial partners, creating a synergistic loop for product and market development. This strategic approach not only fortifies their market position but also nurtures long-term relationships, underpinning recurring revenues from service contracts and incremental technology upgrades. With a clear focus on driving quality and innovation, Bruker Corporation thrives in a competitive landscape, catering to the evolving needs of scientific discovery and industrial precision.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Bruker Corp is -0.7%, which is below its 3-year median of 8.5%.
Over the last 3 years, Bruker Corp’s Net Margin has decreased from 11% to -0.7%. During this period, it reached a low of -0.7% on Sep 30, 2025 and a high of 14.4% on Dec 31, 2023.